Agilon Health Inc. (AGL) Misses Q4 EPS by 19c

Agilon Health Inc. (NYSE: AGL) reported Q4 EPS of ($0.46), $0.19 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $1.57 billion versus the consensus estimate of $1.46 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Obsidian Energy Increases Syndicated Credit Facility
• BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption